Lofgren syndrome is a recognised acute presentation of sarcoidosis. When erythema nodosum, bilateral hilar adenopathy, fever, and joint pain occur together, this specific constellation defines the clinical picture — and guides the treatment approach.
This protocol covers sarcoidosis presenting as Lofgren syndrome, characterised by all or most of the following features:
Management of this presentation involves a specific class of anti-inflammatory agents targeting the painful skin and joint manifestations — the full selection criteria, sequencing, and any escalation pathways are contained in the complete protocol.
The therapeutic aim is resolution of joint pain and skin lesions. This syndrome typically resolves completely within a few months with appropriate management.
This syndrome, which is also associated with hilar adenopathy, fever and pain in the ankles and other joints, typically resolves completely in a few months.
It can be usually treated with only nonsteroidal drugs for painful skin lesions and joint pain; however, occasionally corticosteroids are required.
View source ↗